Winton Group’s SOPHiA GENETICS SOPH Stock Holding History

Winton Group’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$213K	Buy	+25,400	New	+$183K	0.01%	932

Other funds holding SOPH

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Alta Wealth Advisors Woburn, Massachusetts $380M AUM 32.41% 1-Year Est. Return

Next Century Growth Investors Plymouth, Minnesota $1.57B AUM 96.5% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return

Winton Group's SOPH Position: Q3 2026 in Review

Winton Group opened a new position in SOPHiA GENETICS (SOPH) in Q3 2026: 25,400 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #932 among its holdings.

52 funds tracked by Wall St. Rank hold SOPH as of Q3 2026.

Winton Group held 25,400 shares of SOPHiA GENETICS worth $213K as of Q3 2026.
SOPHiA GENETICS was a new Winton Group position in Q3 2026.
SOPHiA GENETICS made up 0.01% of Winton Group's portfolio in Q3 2026, its #932 holding.
52 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2026.

Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.